We are live on ! Find out more
SRC

Shufro Rose & Co Portfolio holdings

AUM $1.47B
1-Year Est. Return 19.38%
This Fund
S&P 500
This Quarter Est. Return
+8.42%
1 Year Est. Return
+19.38%
3 Year Est. Return
+47.49%
5 Year Est. Return
+55.37%
10 Year Est. Return
+200.77%
AUM
$1.26B
AUM Growth
+$67.8M
Cap. Flow
-$17.4M
Cap. Flow %
-1.38%
Top 10 Hldgs %
38.89%
Holding
321
New
33
Increased
44
Reduced
144
Closed
15

Sector Composition

Rank Sector Weight
1 Technology 22.68%
2 Consumer Discretionary 11.25%
3 Healthcare 10.71%
4 Financials 9.54%
5 Industrials 6.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VCSH icon
176
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$416K 0.03%
5,042
-21,600
-81% -$1.79M
VTI icon
177
Vanguard Morningstar Total Stock Market ETF
VTI
$660B
$414K 0.03%
2,001
-8
-0.4% -$1.62K
GDX icon
178
VanEck Gold Miners ETF
GDX
$22.7B
$406K 0.03%
12,486
-199,225
-94% -$6.79M
AFG icon
179
American Financial Group
AFG
$11.8B
$405K 0.03%
3,550
GSLC icon
180
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
$15.1B
$402K 0.03%
5,080
+1,150
+29% +$89.3K
ICE icon
181
Intercontinental Exchange
ICE
$85.6B
$402K 0.03%
3,600
-104
-3% -$11.8K
VWO icon
182
Vanguard FTSE Emerging Markets ETF
VWO
$121B
$402K 0.03%
7,719
+307
+4% +$16.3K
EFR
183
Eaton Vance Senior Floating-Rate Fund
EFR
$314M
$400K 0.03%
29,000
HCSG icon
184
Healthcare Services Group
HCSG
$1.6B
$400K 0.03%
14,275
-300
-2% -$9.06K
NVS icon
185
Novartis
NVS
$297B
$397K 0.03%
4,640
-528
-10% -$47.4K
EFT
186
Eaton Vance Floating-Rate Income Trust
EFT
$283M
$396K 0.03%
28,100
REGN icon
187
Regeneron Pharmaceuticals
REGN
$78.5B
$393K 0.03%
830
PARA
188
DELISTED
Paramount Global Class B
PARA
$392K 0.03%
8,682
-9,599
-53% -$586K
GATX icon
189
GATX Corp
GATX
$6.35B
$390K 0.03%
4,200
FEIM icon
190
Frequency Electronics
FEIM
$635M
$386K 0.03%
34,161
VEA icon
191
Vanguard FTSE Developed Markets ETF
VEA
$229B
$382K 0.03%
7,780
+1,979
+34% +$96.7K
ADP icon
192
PUT
Automatic Data Processing
ADP
$106B
$377K 0.03%
2,000
GILD icon
193
Gilead Sciences
GILD
$162B
$377K 0.03%
5,839
AMWL icon
194
American Well
AMWL
$180M
$375K 0.03%
+1,080
New +$585K
VLY icon
195
Valley National Bancorp
VLY
$7.9B
$374K 0.03%
27,200
-3,500
-11% -$42.2K
VLO icon
196
Valero Energy
VLO
$90.1B
$373K 0.03%
5,203
VBR icon
197
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.1B
$368K 0.03%
+2,220
New +$350K
PFN
198
PIMCO Income Strategy Fund II
PFN
$698M
$366K 0.03%
35,650
SJM icon
199
J.M. Smucker
SJM
$12.7B
$364K 0.03%
2,877
CVET
200
DELISTED
Covetrus, Inc. Common Stock
CVET
$363K 0.03%
12,100

Similar funds

Shufro Rose & Co's Q1 2021 Portfolio in Review

As of Q1 2021, Shufro Rose & Co held 321 positions worth $1.26B, up 5.7% from $1.19B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Shufro Rose & Co's Q1 2021 filing shows 33 new, 44 increased, 144 reduced and 15 closed positions. Its largest new stake was Goldman Sachs ActiveBeta Emerging Markets Equity ETF: 158,873 shares worth $6.27M. The largest sale was State Street SPDR Portfolio Short Term Corporate Bond ETF, an estimated $27.6M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Shufro Rose & Co's largest Q1 2021 buy was Goldman Sachs ActiveBeta Emerging Markets Equity ETF: 158,873 shares worth $6.27M.
  • Shufro Rose & Co added most to JPMorgan Ultra-Short Income ETF in Q1 2021, an estimated $70.7M increase.
  • Shufro Rose & Co's biggest Q1 2021 reduction was State Street SPDR Portfolio Short Term Corporate Bond ETF, cutting an estimated $27.6M.
  • Shufro Rose & Co fully exited DuPont de Nemours in Q1 2021, selling an estimated $3.44M.
  • Shufro Rose & Co's ten largest holdings make up 39% of its $1.26B portfolio in Q1 2021.
  • Shufro Rose & Co opened 33 new positions and closed 15 in Q1 2021.
  • Shufro Rose & Co's portfolio value rose 5.7% quarter-over-quarter to $1.26B.

Based on Shufro Rose & Co's 13F filing for Q1 2021, filed 28 Apr 2021.